Higher Lifetime Stress and Symptom Burden Contribute to the Occurrence of Shortness of Breath
- PMID: 37500312
- PMCID: PMC11446157
- DOI: 10.1016/j.soncn.2023.151471
Higher Lifetime Stress and Symptom Burden Contribute to the Occurrence of Shortness of Breath
Abstract
Objectives: Among four classes of patients with distinct shortness of breath profiles, evaluate for differences in levels of global, cancer-specific, and cumulative life stress, as well as resilience; evaluate for differences in the occurrence rates for various stressful life events, and evaluate for differences in the severity of common co-occurring symptoms.
Data sources: Outpatients (N = 1338) completed questionnaires six times over two cycles of chemotherapy. The occurrence of shortness of breath was assessed using the Memorial Symptom Assessment Scale. Latent class analysis was used to identify subgroups of patients with distinct shortness of breath profiles. Differences among the classes were evaluated using parametric and nonparametric tests.
Conclusion: Shortness of breath classes were labeled based on their distinct occurrence trajectories: None (70.5%), Decreasing (8.2%), Increasing (7.8%), and High (13.5%). Compared to None class, Decreasing and High classes had higher global and cancer-specific stress scores. The High class reported higher occurrence rates for several adverse childhood experiences. Compared to None class, Decreasing and High classes had higher depression, anxiety, and morning fatigue scores and lower morning energy and cognitive function scores.
Implications for nursing practice: Given the additive or synergistic relationships between stress, co-occurring symptoms, and shortness of breath, multimodal interventions that include stress management, exercise training, and/or symptom management may decrease shortness of breath in oncology patients.
Keywords: Adverse childhood experiences; Cancer; Depression; Post-traumatic stress disorder; Resilience; Shortness of breath; Stress.
Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest Dr. Wong reported conflicts of interest outside of the submitted work: An immediate family member is an employee of Genentech with stock ownership and Dr. Wong receives royalties from UpToDate. The remaining authors have no conflicts of interest to declare.
Similar articles
-
Common and distinct risk factors that influence more severe and distressing shortness of breath profiles in oncology outpatients.Cancer Med. 2024 Feb;13(3):e7013. doi: 10.1002/cam4.7013. Cancer Med. 2024. PMID: 38400684 Free PMC article.
-
Distinct Shortness of Breath Profiles in Oncology Outpatients Undergoing Chemotherapy.J Pain Symptom Manage. 2023 Mar;65(3):242-255. doi: 10.1016/j.jpainsymman.2022.11.010. Epub 2022 Nov 21. J Pain Symptom Manage. 2023. PMID: 36423799 Free PMC article.
-
Worse Morning Energy Profiles Are Associated with Significant Levels of Stress and Decrements in Resilience in Patients Receiving Chemotherapy.Semin Oncol Nurs. 2024 Oct;40(5):151718. doi: 10.1016/j.soncn.2024.151718. Epub 2024 Aug 20. Semin Oncol Nurs. 2024. PMID: 39164158
-
Telephone interventions for symptom management in adults with cancer.Cochrane Database Syst Rev. 2020 Jun 2;6(6):CD007568. doi: 10.1002/14651858.CD007568.pub2. Cochrane Database Syst Rev. 2020. PMID: 32483832 Free PMC article.
-
Female With Shortness of Breath.J Am Coll Emerg Physicians Open. 2025 Jun 17;6(4):100206. doi: 10.1016/j.acepjo.2025.100206. eCollection 2025 Aug. J Am Coll Emerg Physicians Open. 2025. PMID: 40600001 Free PMC article. Review. No abstract available.
Cited by
-
Common and distinct risk factors that influence more severe and distressing shortness of breath profiles in oncology outpatients.Cancer Med. 2024 Feb;13(3):e7013. doi: 10.1002/cam4.7013. Cancer Med. 2024. PMID: 38400684 Free PMC article.
References
-
- Shin J, Kober K, Wong ML, Yates P, Miaskowski C. Systematic review of the literature on the occurrence and characteristics of dyspnea in oncology patients. Crit Rev Oncol Hematol. 2022. 103870. - PubMed
-
- Hui D, Bohlke K, Bao T, et al. Management of dyspnea in advanced cancer: ASCO guideline. J Clin Oncol. 2021;39(12):1389–1411. - PubMed
-
- Silvoniemi M, Vasankari T, Loyttyniemi E, Valtonen M, Salminen E. Symptom assessment for patients with non-small cell lung cancer scheduled for chemotherapy. Anticancer Res. 2016;36(8):4123–4128. - PubMed
-
- Kocher F, Hilbe W, Seeber A, et al. Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registry. Lung Cancer. 2015;87(2):193–200. - PubMed